529    Table 4. Treatment-Emergent Adverse Events in Placebo-Controlled Trials*

 

Body/System

Adverse Event

WELLBUTRIN SR

300 mg/day

(n=376)

WELLBUTRIN SR

400mg/day

(n=114)

 

Placebo

(n=385)

Body (General)

    Headache

    Infection

    Abdominal Pain

    Asthenia

    Chest pain

    Pain

    Fever

 

26%

8%

3%

2%

3%

2%

1%

 

25%

9%

9%

4%

4%

3%

2%

 

23%

6%

2%

2%

1%

2%

-

Cardiovascular

    Palpitation

    Flushing

    Migraine

    Hot flashes

 

2%

1%

1%

1%

 

6%

4%

4%

3%

 

2%

-

1%

1%

Digestive

    Dry mouth

    Nausea

    Constipation

    Diarrhea

    Anorexia

    Vomiting

    Dysphagia

 

17%

13%

10%

5%

5%

4%

0%

 

24%

18%

5%

7%

3%

2%

2%

 

7%

8%

7%

6%

2%

2%

0%

Musculoskeletal

    Myalgia

    Arthralgia

    Arthritis

    Twitch

 

2%

1%

0%

1%

 

6%

4%

2%

2%

 

3%

1%

0%

-

Nervous system

    Insomnia

    Dizziness

    Agitation

    Anxiety

    Tremor

    Nervousness

    Somnolence

 

11%

7%

3%

5%

6%

5%

2%

 

16%

11%

9%

6%

3%

3%

3%

 

6%

5%

2%

3%

1%

3%

2%

 

 

 

16

 

 

 

 

 

Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page

Hosted by www.Geocities.ws

1